查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886063

全球免疫蛋白诊断检测市场

Immunoprotein Diagnostic Testing
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到2030年，全球免疫蛋白诊断检测市场规模将达226亿美元。

全球免疫蛋白诊断测试市场规模在2024年估计为167亿美元，预计到2030年将达到226亿美元，在分析期（2024-2030年）内复合年增长率（CAGR）为5.2%。本报告分析的细分市场之一—免疫球蛋白诊断测试，预计将以6.0%的复合年增长率成长，并在分析期结束时达到64亿美元。游离轻链诊断测试细分市场预计在分析期间内将以4.2%的复合年增长率成长。

美国市场规模估计为46亿美元，而中国市场预计将以4.8%的复合年增长率成长。

预计到2024年，美国免疫蛋白诊断检测市场规模将达46亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到35亿美元，2024年至2030年的复合年增长率（CAGR）为4.8%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率将分别达到5.0%和4.2%。在欧洲，德国的复合年增长率预计将达到约4.3%。

全球免疫蛋白诊断检测市场—主要市场趋势与驱动因素概述

为什么免疫蛋白诊断检测正逐渐成为疾病诊断与管理的重要工具

免疫蛋白诊断检测已成为早期发现、诊断和后续观察多种疾病和健康状况（包括自体免疫疾病、感染疾病、心血管疾病和癌症）的重要工具。这些检测旨在测量血液、血清或血浆样本中特定免疫蛋白的水平，例如免疫球蛋白（IgA、IgG、IgM）、C反应蛋白（CRP）、补体蛋白和类风湿因子。透过检测这些蛋白的异常浓度，免疫蛋白诊断检测能够提供有关发炎反应、免疫系统活性和疾病状态的重要资讯。慢性病和自体免疫疾病的日益增多，以及对准确可靠的诊断工具的需求不断增长，正推动着全球临床检查室、医院和研究机构对免疫蛋白检测的广泛应用。

此外，检查室自动化技术的进步、就地检验（POC​​T）需求的增长以及预防医学意识的提高等因素，进一步推动了全球免疫蛋白诊断检测市场的发展。自动化免疫检测设备和多重检测平台等技术创新，实现了更快、更准确、更经济高效的诊断流程，进而提高了临床检查室的效率和生产力。此外，人们对预防医学和疾病早期检测的日益关注，也推动了对免疫蛋白诊断检测的需求，这些检测能够提供有价值的信息，帮助医疗专业人员及时采取干预措施。免疫蛋白诊断在肿瘤学、感染疾病控制和个人化医疗等领域的广泛应用，使该市场成为现代医疗保健的关键组成部分，有助于改善患者预后，并为临床决策提供更充分的资讯。

哪些技术进步将改变免疫蛋白诊断检测市场？

技术创新正在革新免疫蛋白诊断检测市场，显着提升检测流程的准确性、速度与便利性。其中最具影响力的创新之一是高灵敏度和高特异性免疫检测的开发，例如化学冷光酵素免疫分析法免疫检测(ELISA)、化学发光免疫检测(CLIA) 和放射免疫分析 (RIA)。这些先进的检测技术能够检测到极微量的免疫蛋白，在临床症状出现之前即可对疾病进行早期诊断。能够同时进行多项检测的自动化免疫检测设备的引入，简化了临床检查室的工作流程，缩短了检测结果的返回时间，并最大限度地减少了人为误差。这些系统还具备高通量检测能力，使其成为大规模筛检计画和医院环境的理想选择。

另一项变革性的技术进步是就地检验（POC​​T）设备的兴起，它能够在患者床边、门诊甚至家中快速进行免疫蛋白质诊断。 POCT设备设计易于使用、便于携带，并可在数分钟内提供准确结果，从而加快临床决策速度，并减少对中心检查室检测的需求。 POCT中横向流动化验、生物感测器和微流体装置的应用，正在扩大免疫蛋白质诊断的覆盖范围，尤其是在传统检测设施有限的农村和医疗资源匮乏地区。此外，数位健康技术的整合，例如连接和数据共用功能，使得免疫蛋白质水平的即时监测和分析成为可能，从而支持远端医疗和远端患者管理。

其他创新包括应用多重检测平台和生物晶片技术，这些技术能够同时检测单一检体中的多种免疫蛋白质。这些技术能够提供患者免疫反应的详细图谱，从而更全面地了解疾病状态。人工智慧 (AI) 和机器学习 (ML) 演算法的整合也增强了对复杂免疫蛋白数据的解读，能够更准确地识别模式并预测疾病风险。 AI 驱动的诊断平台能够分析大规模数据集，并为临床医生提供可操作的见解，从而帮助个人化和精准医疗转型。这些技术进步正在革新免疫蛋白诊断检测领域，使更快、更可靠、更全面的诊断解决方案成为可能，以满足现代医疗保健不断变化的需求。

市场动态与监管标准如何影响免疫蛋白诊断检测市场？

免疫蛋白诊断检测市场受复杂的市场动态和监管标准的影响，这些因素影响着产品的开发、应用和可及性。推动市场发展的关键因素之一是慢性病、自体免疫疾病和感染疾病的日益流行，这促使人们对能够早期、准确检测疾病的诊断工具的需求不断增长。随着类风湿性关节炎、全身性红斑性狼疮和多发性硬化症等疾病的全球负担持续加重，迫切需要能够评估免疫功能、监测疾病活动和评估治疗反应的免疫蛋白诊断检测。在肿瘤学领域，免疫蛋白标记被用于检测和后续观察某些类型的癌症，例如前列腺癌（使用前列腺特异性抗原：PSA）和多发性骨髓瘤（使用β2-微球蛋白），从而为治疗决策和预后评估提供宝贵资讯。

监管标准和合规要求在塑造免疫蛋白诊断检测市场方面也发挥关键作用。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等监管机构制定了严格的诊断检测开发、核准和商业化指南，以确保其安全性、有效性和可靠性。遵守这些法规对于製造商成功进入市场并维持医疗服务提供者和患者的信任至关重要。监管环境正在不断发展，以跟上诊断技术的进步，尤其是在就地检验和数位健康解决方案方面。例如，FDA 的紧急使用授权 (EUA) 流程在 COVID-19 大流行期间被广泛用于促进诊断检测的快速供应，这凸显了建立一个灵活敏捷的法规结构的必要性，该框架既能支持创新，又能确保患者安全。随着新的诊断技术和平台的出现，监管机构正在完善政策，以解决资料隐私、网路安全和临床检验等问题，这些问题对于确保免疫蛋白诊断检测的品质和完整性至关重要。

市场动态，例如製造商之间的竞争、价格压力和医疗报销政策，也会影响免疫蛋白诊断检测市场。竞争格局的特点是既有老牌企业，也有新参与企业，它们都在努力开发创新的诊断解决方案，并在这个快速发展的市场中站稳脚跟。各公司透过产品创新、策略联盟以及提供涵盖检测设备、软体、数据分析和支援服务的综合诊断解决方案来脱颖而出。价格压力，尤其是在成本敏感市场，正在推动对兼具高性能和高品质且价格合理的诊断测试的需求。此外，医疗报销政策和支付方的核保决策也在影响免疫蛋白诊断检测的普及。不同地区的报销环境差异显着，并受多种因素影响，例如检测的临床效用、替代诊断方案的可用性以及整体医疗预算。对于在免疫蛋白诊断检测市场中运作的公司而言，充分了解市场动态和监管标准至关重要，这将有助于它们扩大市场份额，并满足患者和医疗服务提供者未被满足的诊断需求。

推动免疫蛋白诊断检测市场扩张的关键成长要素有哪些？

全球免疫蛋白诊断检测市场的成长受多种关键因素驱动，包括慢性病和自体免疫疾病发生率的上升、对疾病早期检测和预防保健的日益重视，以及诊断技术的进步。其中一个关键成长要素是慢性病和自体免疫疾病盛行率的不断攀升，这导致对能够早期准确检测疾病的诊断测试的需求显着增加。特别是自体免疫疾病，由于其症状复杂且相互重迭，往往难以诊断。免疫蛋白诊断测试提供了一种可靠的方法来检测自体免疫标记并评估疾病活动度，从而实现早期诊断和更有效的疾病管理。随着全球人口老化加剧和这些疾病发病率持续上升，预计对免疫蛋白诊断测试的需求将会增加，从而推动市场扩张。

另一个关键成长要素是人们对疾病早期检测和预防保健日益增长的兴趣。早期发现心血管疾病、糖尿病和癌症等疾病可以显着改善治疗效果并降低医疗成本。免疫蛋白诊断测试能够检测发炎、感染疾病和恶性肿瘤的早期生物标记物，目前正被用于筛检风险因子和监测疾病进展。对预防保健的日益重视促使医疗服务提供者和患者都采用能够在健康问题出现临床症状之前识别它们的诊断测试。这一趋势在北美和欧洲等已开发地区尤其明显，这些地区的医疗保健系统越来越重视预防保健和健康促进措施。此外，个人化医疗的兴起正在推动免疫蛋白诊断技术的应用，以根据个别患者的情况制定治疗策略，从而进一步促进市场成长。

诊断检测技术的进步也推动了免疫蛋白诊断检测市场的成长。高通量免疫检测平台、就地检验设备和数位健康解决方案等创新技术，使诊断检测更加便利、准确且易用。能够从单一检体中检测多种生物标记的多重检测平台，提供了更全面的疾病状态信息，从而实现更精准的诊断和监测。连接性和数据共用等数位技术的应用，促进了免疫蛋白诊断融入更广泛的医疗保健生态系统，支援远端医疗和远距患者管理。随着技术创新不断提升免疫蛋白诊断检测的效能和可及性，对早期检测和个人化医疗的日益重视，预计将推动全球免疫蛋白诊断检测市场持续成长，而这主要得益于医疗服务提供者和患者对更有效诊断解决方案的需求不断增长。

部分：

按类型（免疫球蛋白诊断、游离轻链诊断、前白蛋白诊断、结合结合球蛋白蛋白诊断、C反应蛋白诊断、补体系统蛋白诊断、其他类型）；按技术（酵素免疫分析法、免疫比浊法、放射免疫测定、免疫蛋白免疫检测、其他技术）；依应用（传染病检查、肿瘤检测、自体免疫免疫检测、内分泌检测、过敏检测、其他技术检测、过敏检测、其他技术检测）

受访公司范例

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP12539

Global Immunoprotein Diagnostic Testing Market to Reach US$22.6 Billion by 2030

The global market for Immunoprotein Diagnostic Testing estimated at US$16.7 Billion in the year 2024, is expected to reach US$22.6 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by the end of the analysis period. Growth in the Free Light Chain Diagnostic Testing segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.6 Billion While China is Forecast to Grow at 4.8% CAGR

The Immunoprotein Diagnostic Testing market in the U.S. is estimated at US$4.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Immunoprotein Diagnostic Testing Market - Key Trends & Drivers Summarized

Why is Immunoprotein Diagnostic Testing Emerging as a Vital Tool in Disease Diagnosis and Management?

Immunoprotein diagnostic testing has become an indispensable tool in the early detection, diagnosis, and monitoring of various diseases and health conditions, including autoimmune disorders, infectious diseases, cardiovascular diseases, and cancer. These tests are designed to measure the levels of specific immunoproteins-such as immunoglobulins (IgA, IgG, IgM), C-reactive protein (CRP), complement proteins, and rheumatoid factors-in blood, serum, or plasma samples. By detecting abnormal concentrations of these proteins, immunoprotein diagnostic tests provide crucial insights into the presence and progression of inflammatory responses, immune system activity, and disease states. The increasing prevalence of chronic and autoimmune diseases, along with the growing need for precise and reliable diagnostic tools, is driving the adoption of immunoprotein testing across clinical laboratories, hospitals, and research institutions worldwide.

The global immunoprotein diagnostic testing market is further fueled by advancements in laboratory automation, the rising demand for point-of-care testing (POCT), and the growing awareness of preventive healthcare. Technological innovations such as automated immunoassay analyzers and multiplex testing platforms are enabling faster, more accurate, and cost-effective diagnostic processes, enhancing the efficiency and productivity of clinical laboratories. Moreover, the increasing focus on preventive healthcare and early disease detection is boosting the demand for immunoprotein diagnostic tests as they provide valuable information that helps healthcare providers initiate timely interventions. The expanding applications of immunoprotein diagnostics in oncology, infectious disease management, and personalized medicine are positioning this market as a critical component of modern healthcare, supporting better patient outcomes and more informed clinical decision-making.

What Technological Advancements Are Transforming the Immunoprotein Diagnostic Testing Market?

Technological advancements are significantly transforming the immunoprotein diagnostic testing market by enhancing the accuracy, speed, and convenience of testing procedures. One of the most impactful innovations is the development of high-sensitivity and high-specificity immunoassays, such as enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), and radioimmunoassays (RIA). These advanced assay technologies enable the detection of even minute concentrations of immunoproteins, making it possible to diagnose diseases at very early stages when clinical symptoms may not yet be apparent. The introduction of automated immunoassay analyzers that can perform multiple tests simultaneously is streamlining workflow in clinical laboratories, reducing turnaround times, and minimizing the potential for human error. These systems are also capable of handling high-throughput testing, making them ideal for large-scale screening programs and hospital settings.

Another transformative technological advancement is the rise of point-of-care testing (POCT) devices that allow for rapid immunoprotein diagnostics at the patient’s bedside, in outpatient settings, or even at home. POCT devices are designed to be user-friendly, portable, and capable of delivering accurate results within minutes, facilitating faster clinical decisions and reducing the need for centralized laboratory testing. The use of lateral flow assays, biosensors, and microfluidic devices in POCT is expanding the accessibility of immunoprotein diagnostics to a wider population, particularly in rural and underserved areas where access to traditional laboratory facilities may be limited. Additionally, the integration of digital health technologies, such as connectivity features and data-sharing capabilities, is enabling real-time monitoring and analysis of immunoprotein levels, supporting telemedicine and remote patient management.

Further innovations include the application of multiplex testing platforms and biochip technologies, which allow for the simultaneous measurement of multiple immunoproteins from a single sample. These technologies are providing a more comprehensive understanding of disease states by offering a detailed profile of the patient’s immune response. The integration of artificial intelligence (AI) and machine learning (ML) algorithms is also enhancing the interpretation of complex immunoprotein data, identifying patterns, and predicting disease risk with greater accuracy. AI-driven diagnostic platforms can analyze large datasets and provide clinicians with actionable insights, supporting the shift towards personalized and precision medicine. These technological advancements are revolutionizing the field of immunoprotein diagnostic testing, making it possible to deliver faster, more reliable, and more comprehensive diagnostic solutions that cater to the evolving needs of modern healthcare.

How Are Market Dynamics and Regulatory Standards Influencing the Immunoprotein Diagnostic Testing Market?

The immunoprotein diagnostic testing market is shaped by a complex set of market dynamics and regulatory standards that are influencing product development, adoption, and accessibility. One of the primary market drivers is the increasing prevalence of chronic diseases, autoimmune disorders, and infections, which is creating a growing demand for diagnostic tools that can provide early and accurate disease detection. As the global burden of diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis continues to rise, there is a heightened need for immunoprotein diagnostic tests that can assess immune function, monitor disease activity, and evaluate treatment efficacy. In oncology, immunoprotein markers are being used to detect and monitor certain types of cancers, such as prostate cancer (using prostate-specific antigen, or PSA) and multiple myeloma (using beta-2 microglobulin), providing valuable information for guiding treatment decisions and assessing prognosis.

Regulatory standards and compliance requirements are also playing a critical role in shaping the immunoprotein diagnostic testing market. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established stringent guidelines for the development, approval, and commercialization of diagnostic tests to ensure their safety, efficacy, and reliability. Compliance with these regulations is essential for manufacturers to gain market access and maintain the trust of healthcare providers and patients. The regulatory landscape is evolving to keep pace with advances in diagnostic technologies, particularly with regard to point-of-care testing and digital health solutions. For instance, the FDA’s Emergency Use Authorization (EUA) process, which was widely used during the COVID-19 pandemic to expedite the availability of diagnostic tests, has highlighted the need for flexible and responsive regulatory frameworks that can support innovation while ensuring patient safety. As new diagnostic technologies and platforms emerge, regulatory agencies are refining their policies to address issues such as data privacy, cybersecurity, and clinical validation, which are critical for ensuring the quality and integrity of immunoprotein diagnostic tests.

Market dynamics such as competition among manufacturers, pricing pressures, and healthcare reimbursement policies are also influencing the immunoprotein diagnostic testing market. The competitive landscape is characterized by the presence of both established players and new entrants, each striving to develop novel diagnostic solutions and gain a foothold in this rapidly evolving market. Companies are differentiating themselves through product innovation, strategic partnerships, and the ability to offer comprehensive diagnostic solutions that include not only testing devices but also software, data analytics, and support services. Pricing pressures, particularly in cost-sensitive markets, are driving the demand for cost-effective diagnostic tests that offer high performance without compromising quality. Additionally, healthcare reimbursement policies and coverage decisions by payers are impacting the adoption of immunoprotein diagnostic tests. The reimbursement environment varies significantly across regions and is influenced by factors such as the clinical utility of the test, the availability of alternative diagnostic options, and the overall healthcare budget. Navigating these market dynamics and regulatory standards is essential for companies operating in the immunoprotein diagnostic testing market as they seek to expand their presence and address the unmet diagnostic needs of patients and healthcare providers.

What Are the Key Growth Drivers Fueling the Expansion of the Immunoprotein Diagnostic Testing Market?

The growth in the global immunoprotein diagnostic testing market is driven by several key factors, including the rising incidence of chronic and autoimmune diseases, increasing focus on early disease detection and preventive healthcare, and advancements in diagnostic technologies. One of the primary growth drivers is the growing prevalence of chronic and autoimmune diseases, which is creating a significant demand for diagnostic tests that can provide early and accurate detection. Autoimmune diseases, in particular, are often difficult to diagnose due to their complex and overlapping symptoms. Immunoprotein diagnostic tests offer a reliable means of detecting autoimmune markers and assessing disease activity, enabling earlier diagnosis and more effective disease management. As the global population ages and the incidence of these conditions continues to rise, the demand for immunoprotein diagnostics is expected to increase, supporting market expansion.

Another significant growth driver is the increasing focus on early disease detection and preventive healthcare. Early detection of diseases such as cardiovascular disease, diabetes, and cancer can significantly improve treatment outcomes and reduce healthcare costs. Immunoprotein diagnostic tests, which can detect early biomarkers of inflammation, infection, and malignancy, are being used to screen for risk factors and monitor disease progression. The growing emphasis on preventive healthcare is encouraging healthcare providers and patients to adopt diagnostic tests that can identify health issues before they become clinically apparent. This trend is particularly strong in developed regions such as North America and Europe, where healthcare systems are increasingly prioritizing preventive care and wellness initiatives. Additionally, the rise of personalized medicine is driving the use of immunoprotein diagnostics to tailor treatment strategies based on individual patient profiles, further supporting market growth.

Technological advancements in diagnostic testing are also fueling the growth of the immunoprotein diagnostic testing market. Innovations such as high-throughput immunoassay platforms, point-of-care testing devices, and digital health solutions are making diagnostic tests more accessible, accurate, and user-friendly. The development of multiplex testing platforms that can measure multiple biomarkers from a single sample is providing a more comprehensive view of disease states, enabling more precise diagnosis and monitoring. The adoption of digital technologies, such as connectivity features and data-sharing capabilities, is enhancing the integration of immunoprotein diagnostics into broader healthcare ecosystems, supporting telemedicine and remote patient management. As technological innovations continue to improve the performance and accessibility of immunoprotein diagnostic tests, and as the focus on early detection and personalized medicine grows, the global immunoprotein diagnostic testing market is poised for sustained growth, driven by increasing demand from healthcare providers and patients seeking more effective diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Immunoprotein Diagnostic Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic, Other Types); Technology (Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis, Other Technologies); Application (Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Immunoprotein Diagnostic Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Drives Growth in Immunoprotein Diagnostic Testing Market
    • Expansion of Autoimmune Disease and Cancer Diagnostics Spurs Adoption of Immunoprotein Testing
    • Growth in Focus on Early Disease Detection Expands Addressable Market for Immunoprotein Diagnostic Testing
    • Growth in Use of Immunoprotein Testing for Cardiovascular Disease and Inflammatory Disorders Expands Market Opportunities
    • Increasing Focus on Immunoprotein Diagnostic Testing for Infectious Disease Detection Expands Addressable Market
    • Role of Immunoprotein Testing in Supporting Disease Monitoring and Treatment Response Strengthens Market Demand
    • Growth in Use of Immunoprotein Testing for Cancer Prognosis and Therapy Monitoring Expands Market Reach
    • Growth in Use of Immunoprotein Diagnostic Testing for Allergy and Autoimmune Disorders Fuels Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Immunoprotein Diagnostic Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoglobulin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunoglobulin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Immunoglobulin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Free Light Chain Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Free Light Chain Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Free Light Chain Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pre-Albumin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pre-Albumin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pre-Albumin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Haptoglobin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Haptoglobin Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Haptoglobin Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for C-Reactive Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for C-Reactive Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for C-Reactive Protein Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Complement System Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Complement System Protein Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Complement System Protein Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Enzyme-Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Enzyme-Linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Enzyme-Linked Immunosorbent Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Immunoturbidity Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Radioimmunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Immunoprotein Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Immunoprotein Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Immunoprotein Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Autoimmune Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Autoimmune Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Autoimmune Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Endocrine Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Allergy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 62: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 110: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunoprotein Diagnostic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 164: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Type - Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Type - Percentage Breakdown of Value Sales for Immunoglobulin Diagnostic, Free Light Chain Diagnostic, Pre-Albumin Diagnostic, Haptoglobin Diagnostic, C-Reactive Protein Diagnostic, Complement System Protein Diagnostic and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Linked Immunosorbent Assay, Immunoturbidity Assay, Radioimmunoassay, Immunoprotein Electrophoresis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of World Recent Past, Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of World Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Autoimmune Testing, Endocrine Testing, Allergy Testing, Toxicology Testing and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION